Quote | Gelteq Limited (NASDAQ:GELS)
Last: | $1.386 |
---|---|
Change Percent: | 1.17% |
Open: | $1.38 |
Close: | $1.37 |
High: | $1.47 |
Low: | $1.37 |
Volume: | 67,592 |
Last Trade Date Time: | 05/12/2025 11:10:41 am |
News | Gelteq Limited (NASDAQ:GELS)
2025-05-10 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...
2025-05-03 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...
Message Board Posts | Gelteq Limited (NASDAQ:GELS)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Gelteq Limited Company Name:
GELS Stock Symbol:
NASDAQ Market:
1.17% G/L:
$1.386 Last:
67,592 Volume:
$1.38 Open:
$1.37 Close:
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces today that its sport-fo...
NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces the launch of its Sport...
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment o...